Detalhe da pesquisa
1.
Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2+ and TLR4+ Th17/Tc17-like cells in multiple sclerosis patients with major depression.
Immunology
; 162(3): 290-305, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33112414
2.
Major Depressive Disorder Enhances Th2 and Th17 Cytokines in Patients Suffering from Allergic Rhinitis and Asthma.
Int Arch Allergy Immunol
; 182(12): 1155-1168, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34348317
3.
Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4+ T-cell subsets in multiple sclerosis patients.
Eur J Immunol
; 48(8): 1376-1388, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29719048
4.
TLR-2 and TLR-4 agonists favor expansion of CD4+ T cell subsets implicated in the severity of neuromyelitis optica spectrum disorders.
Mult Scler Relat Disord
; 34: 66-76, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31229737